Replies to post #20425 on Bioelectronics Corp (BIEL)

[Simpsonly]

Maybe BIEL management members know, I have no clue. If I were involved, the lines of communication between J&J and BIEL would already be open. And a few other chemical painkiller manufacturers.

I posed a couple of months ago what the J&J board meeting would sound like if BIEL gets its approval on ActiPatch and ALLAY and someone is asked by the directors why J&J wasn't all over BIEL as a hedge against the two products cutting into Tuylenol sales. Oooooops, sorry boss, had no idea.

And here we are a couple of months later with Alex Gorsky, who until his recent promotion to CEO headed up the J&J Device Division. This could become a best-seller if BIEL gets the approvals.